Down Syndrome and Continuous Positive Pressure Therapy

Institut Jerome Lejeune31 enrolled

Overview

The purpose of this study is to evaluate the efficacy and tolerability of Continuous Positive Pressure for SAOS in Down Syndrome patients.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Down Syndrome Obstructive Sleep Apnea Syndrome

Interventions

Continuous Positive PressureDEVICE

Nighttime continuous positive pressure device, to be used every day

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Down Syndrome patients with an Obstructive Sleep Apnea Syndrome * more than 18 years old Exclusion Criteria: * predictable non-compliance of device * non-compensated cardiopathy * non-stable thyroxin treatment * non-stable diabetes

Locations (1)

Institut Jerome Lejeune

Paris, France

Outcomes

Primary Outcomes

Scores on psychometrical and dementia scales after a 3-month treatment period (and if possible, after 12 months)

Time frame: 0 and 3 months

Secondary Outcomes

Tolerability

Time frame: 0, 3 and 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.